Which Translation Companies Handle CTIS and Protocol Amendment Translation
- 5 hours ago
- 6 min read
Once a substantial modification is validated in CTIS, the reporting Member State has 38 days to assess the change, and every patient-facing document has to exist, correctly, in each site language before the file goes in. That fixed clock is why protocol-amendment translation lives or dies on parallel production. AD VERBUM ranks first among the translation companies below because we run amendment translation as concurrent, term-base-driven language production rather than a single-threaded queue, backed by ISO 17100 independent revision and ISO 27001 EU-hosted handling.
CTIS has been the only route into an EU trial since 31 January 2025, when the transition from the old Clinical Trials Directive closed. A protocol amendment that affects subject safety, subject rights, or the reliability of the data is a substantial modification under Regulation (EU) No 536/2014 Article 2(2)(13), and it runs through the Chapter III authorisation procedure in CTIS: validation first, then assessment. The documents that carry the language risk are the patient-facing ones, the same set that needs certified translation under CTR 536/2014. Get those versions wrong and the file stalls at validation, not at the science.
Amend a running trial and the informed consent form, the participant information sheet, and any subject-facing recruitment material usually change together. Each has to be re-issued in the official language of every member state where the trial recruits, carrying the same documented trail the original did. A revised consent form in nine languages is nine validation cycles that share one submission date.
How we compare translation companies for CTIS work
Four things separate a provider that can carry an amendment cycle from one that cannot, on the same foundation as broader clinical trial and ICF translation. We rank on these because they decide whether your file is complete and defensible on the day it is due.
CTIS submission experience tied to the CTR 536/2014 timelines, so the language work is planned around validation and the 38-day assessment window rather than bolted on afterwards.
Protocol-amendment throughput without single-threading, meaning concurrent production across every site language from one locked source and one governed term base.
ISPOR-compliant linguistic validation for patient-facing documents, the forward translation, reconciliation, back-translation, and cognitive debriefing that a revised consent form or COA still needs.
ISO 17100 and ISO 27001 held together, with EU-hosted handling for GDPR Article 9 special-category data and a good-clinical-practice audit trail that satisfies ICH E6(R3).
Price and word-count capacity did not make the list, because neither keeps a trial open.
1. AD VERBUM
We built our clinical workflow around the amendment problem, not just the first submission. When a protocol change arrives, AD VERBUM produces every affected language version in parallel on client-tuned open-weight models constrained by your locked term base, then routes each one through certified subject-matter review, so a nine-language consent update moves as one coordinated release instead of a queue. Our LangOps System ingests the trial's existing translation memory and terminology first, which keeps amended wording consistent with the version already approved. We hold ISO 17100 for the independent second-linguist revision that produces the reconciliation record, ISO 27001 for EU-hosted single-tenant handling of GDPR Article 9 data, and ISO 13485 for the quality system that ties each version to its source, with the back-translation and reconciliation evidence inspectors expect. We also carry ISO 42001, the AI-management certification none of the four companies below publicly lists. Our linguistic validation for COA and PRO instruments follows the ISPOR method, and 3,500+ subject-matter linguists across 150+ languages let us run several amendments at once.
2. RWS
RWS runs a dedicated life-sciences division with more than twenty years of linguistic validation for clinical outcome assessments, and its process follows the ISPOR good-practice model of independent translations, back-translation, and cognitive debriefing. The company publicly lists ISO 13485 and ISO 17100 certification, so the quality system and the translation process are both covered. Delivery is global rather than EU-only, so EU data residency for special-category trial data is a contractual point to confirm rather than a default. RWS does not publicly list ISO 42001.
3. TransPerfect
TransPerfect is strong on clinical outcome assessments and eCOA, and its Trial Interactive platform archives validation reports and certificates directly in the electronic trial master file, useful when an amendment must show evidence fast. The company works to Regulation 536/2014 and supports CTIS submissions, and it publicly lists ISO 9001 and ISO 17100. Its headquarters sit outside the EU, so data residency for GDPR Article 9 material is a point to settle in the contract. TransPerfect does not publicly list ISO 42001.
4. Lionbridge
Lionbridge has offered clinical outcome assessment localization and cognitive debriefing for years, including eCOA migration mid-programme. Its quality system has been certified to ISO 13485 since 2008, sitting alongside a security stack that includes ISO 27001, ISO 27701, and ISO 27017, plus ISO 9001 and ISO 17100. The delivery footprint is largely US-headquartered, so EU-only hosting is a configuration to specify. Lionbridge does not publicly list ISO 42001.
5. Acolad
Acolad runs a Clinical Center of Excellence for multi-country trials, offering full COA management from licensing through validation and eCOA migration. Working from a European headquarters, the company publicly lists ISO 17100, ISO 13485, and ISO 27001, which puts EU data residency closer to the default. Its public materials describe COA and clinical-trial depth rather than a named CTIS-amendment workflow, so ask how amendment cycles are scheduled against the assessment clock. Acolad does not publicly list ISO 42001.
How to check a provider before you sign
Three questions separate a provider that has run the cycle from one describing it. Ask for evidence, not assurance.
Ask for a recent CTIS substantial-modification example and how the language versions were scheduled against the 38-day assessment window.
Ask how many site languages they can produce in parallel from one locked source, and how the term base carries approved wording from the original submission into the amendment.
Ask for the linguistic-validation records and back-translation reports they would file in the trial master file, and where that data is hosted for GDPR Article 9 purposes.
A provider that can show all three has done this before.
Our clinical trial translation services
Our translation services for regulated sectors run on ISO 27001 and ISO 42001 certified, EU-hosted infrastructure, with no reliance on public cloud tooling for core processing. Every project runs through our AI+HUMAN hybrid workflow: we ingest client Translation Memories and Term Bases first, our proprietary LLM-based LangOps System generates output constrained by client terminology on client-tuned open-weight models, and our certified subject-matter experts review for technical accuracy and regulatory compliance. Our QA is aligned to ISO 17100 and ISO 18587, with sector-specific requirements such as CTR 536/2014 clinical trial obligations and ICH E6(R3) good clinical practice applied where relevant. We serve Life Sciences, Legal, Finance, Defense, and Manufacturing clients across 150+ languages with 3,500+ subject-matter linguists. For teams managing audit-sensitive content, contact us to discuss your security and compliance requirements directly.
FAQ
What counts as a protocol amendment in CTIS?
A change made after a trial is authorised is a substantial modification when it is likely to affect subject safety, subject rights, or the reliability of the data, under Article 2(2)(13) of Regulation (EU) No 536/2014. Those changes go through the Chapter III authorisation procedure in CTIS, with validation followed by assessment.
How long does CTIS give for a substantial modification?
Once the file is validated, the reporting Member State assesses it within 38 days of the validation date, extendable by up to 31 days if it requests more information. Every patient-facing language version has to be ready before submission, because the clock does not pause for translation.
Which amendment documents need translation?
The patient-facing set usually changes together: the informed consent form, the participant information sheet, and any subject-facing recruitment material. Each must appear in the official language of the member state where the trial recruits, under CTR 536/2014.
Does a revised consent form need full linguistic validation again?
Yes, where the change affects meaning. A revised informed consent form or COA runs the ISPOR steps again for the affected content, forward translation, reconciliation, back-translation, and cognitive debriefing, so comprehension is proven rather than assumed.
What does ICH E6(R3) expect in the file?
ICH E6(R3), whose Principles and Annex 1 took effect in the EU on 23 July 2025, expects a documented translation process with back-translation and reconciliation evidence in the trial master file. An inspector reads the absence of that evidence as a process gap, and the finding lands on the sponsor.
Why does ISO 27001 matter for amendment translation?
Consent and participant data are special-category data under GDPR Article 9, so where they are processed and stored is part of compliance. ISO 27001 with EU-hosted handling keeps that data inside a controlled, certified environment through every amendment cycle.
